Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP)

About

The Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP) provides comprehensive assessment of broadly protective influenza vaccine candidates integrated with fundamental research on protective host responses to provide insight into the mechanisms that drive influenza vaccine effectiveness in the most vulnerable, high-risk populations. Using computational methodologies, broadly reactive hemagglutinin- and neuraminidase-based vaccines are being assessed using cutting-edge scientific and statistical modeling technologies. Additionally, the CIVR-HRP network is investigating novel platforms to deliver universal influenza vaccines, including recombinant proteins, microparticles, live attenuated viruses, and microneedle skin patches. Combining traditional and cutting-edge immunology, epigenetics, structural biology, virology, systems biology, and statistical modeling with various OMICs assessments of host responses to influenza vaccination and infection in high-risk models, the CIVR-HRP is developing the next generation flu vaccines for people and the models needed to predict their effectiveness.

Dr. Ted Ross, Principal Investigator, Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP)

Principal Investigator

PROFESSOR, INFECTIOUS DISEASES 

Director of the Center for Vaccines and Immunology

University of Georgia

Dr. Stacey Shultz-Cherry, co-Principal Investigator, Center for Influenza Vaccine Research for High-Risk Populations (CIVR-HRP)

co-Principal Investigator

PROFESSOR, INFECTIOUS DISEASES 

St. Jude Children’s Research Hospital

Investigators

Emory University

Georgia Tech University

Icahn School of Medicine at Mount Sinai

Mayo Clinic

New York University

New York University Langone Health

  • Drew Jones, PhD, Assistant Professor, Department of Biochemistry and Molecular Pharmacology, NYU Metabolomics Core Resource Laboratory

St. Jude Children’s Research Hospital

Ragon Institute of MGH, MIT, and Harvard

University of Alberta

University of California at Los Angeles

University of California at Santa Cruz

University of Georgia

  • Justin Bahl, PhD, Associate Professor, Department of Infectious Diseases, Institute of Bioinformatics
  • Andreas Handel, PhD, Associate Professor, Department of Epidemiology and Biostatistics
  • Jarrod Mousa, PhD, Assistant Professor , Department of Infectious Diseases, Center for Vaccines and Immunology
  • Karen Norris, PhD, Professor, Department of Infectious Diseases, Center for Vaccines and Immunology
  • Ye Shen, PhD, Associate Professor, Department of Epidemiology and Biostatistics
  • Eva-Maria Strauch, PhD, Assistant Professor, Department of Pharmaceutical and Biomedical Sciences
  • S. Mark Tompkins, PhD, Professor, Department of Infectious Diseases, Center for Vaccines and Immunology

University of Melbourne at the Peter Doherty Institute 

University of North Carolina

University of Rochester

University of Texas

Other Key Personnel

Research Managers

  • Anne Bebin-Blackwell, PhD, Assistant Research Scientist, Center for Vaccines and Immunology, University of Georgia
  • Michael Carlock, Research Professional, Center for Vaccines and Immunology, University of Georgia
  • Pam Frieden, Associate Scientist, Department of Infectious Diseases, St. Jude Children’s Research Hospital

Center Data Manager

  • Lauren Lashua, Research Database Specialist, Department of Biology, New York University

Center Coordinator

  • Kali King, MBA, Associate Director, Center for Vaccines and Immunology, University of Georgia